123 related articles for article (PubMed ID: 16923725)
1. Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients.
Lange T; Jungmann P; Haberle J; Falk S; Duebbers A; Bruns R; Ebner A; Hinterdorfer P; Oberleithner H; Schillers H
Mol Membr Biol; 2006; 23(4):317-23. PubMed ID: 16923725
[TBL] [Abstract][Full Text] [Related]
2. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
4. Determination of CFTR densities in erythrocyte plasma membranes using recognition imaging.
Ebner A; Nikova D; Lange T; Häberle J; Falk S; Dübbers A; Bruns R; Hinterdorfer P; Oberleithner H; Schillers H
Nanotechnology; 2008 Sep; 19(38):384017. PubMed ID: 21832576
[TBL] [Abstract][Full Text] [Related]
5. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
[TBL] [Abstract][Full Text] [Related]
6. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease.
Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T
Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011
[TBL] [Abstract][Full Text] [Related]
7. Localisation of wild-type and DeltaF508-CFTR in nasal epithelial cells.
Dormer RL; McNeilly CM; Morris MR; Pereira MM; Doull IJ; Becq F; Mettey Y; Vierfond JM; McPherson MA
Pflugers Arch; 2001; 443 Suppl 1():S117-20. PubMed ID: 11845316
[TBL] [Abstract][Full Text] [Related]
8. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
Preumont V; Hermans MP; Lebecque P; Buysschaert M
Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503
[TBL] [Abstract][Full Text] [Related]
9. High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA).
Storm K; Moens E; Vits L; De Vlieger H; Delaere G; D'Hollander M; Wuyts W; Biervliet M; Van Schil L; Desager K; Nöthen MM
J Cyst Fibros; 2007 Nov; 6(6):371-5. PubMed ID: 17481968
[TBL] [Abstract][Full Text] [Related]
10. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator in human and mouse red blood cell membranes and its interaction with ecto-apyrase.
Sterling KM; Shah S; Kim RJ; Johnston NI; Salikhova AY; Abraham EH
J Cell Biochem; 2004 Apr; 91(6):1174-82. PubMed ID: 15048872
[TBL] [Abstract][Full Text] [Related]
12. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
14. Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.
Cheung JC; Deber CM
Biochemistry; 2008 Feb; 47(6):1465-73. PubMed ID: 18193900
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling.
Roque T; Boncoeur E; Saint-Criq V; Bonvin E; Clement A; Tabary O; Jacquot J
J Pharmacol Exp Ther; 2008 Sep; 326(3):949-56. PubMed ID: 18574003
[TBL] [Abstract][Full Text] [Related]
16. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations.
Kolesár P; Minárik G; Baldovic M; Ficek A; Kovács L; Kádasi L
Gen Physiol Biophys; 2008 Dec; 27(4):299-305. PubMed ID: 19202204
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
[TBL] [Abstract][Full Text] [Related]
19. Low temperature induces the delivery of mature and immature CFTR to the plasma membrane.
Rennolds J; Boyaka PN; Bellis SL; Cormet-Boyaka E
Biochem Biophys Res Commun; 2008 Feb; 366(4):1025-9. PubMed ID: 18096515
[TBL] [Abstract][Full Text] [Related]
20. A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein.
Farinha CM; Mendes F; Roxo-Rosa M; Penque D; Amaral MD
Mol Cell Probes; 2004 Aug; 18(4):235-42. PubMed ID: 15271383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
